Tethis S.p.A
Tethis S.p.A. is a company focused on revolutionizing cancer management through liquid biopsy. They offer a unique, automated, and standardized approach to processing blood samples, preserving sample integrity for early cancer detection and treatment guidance. Their proprietary See.d® platform and Smart Bio Surface (SBS) slides enable immediate, gentle, and efficient cell adhesion for a total capture approach to liquid biopsy. This allows for comprehensive analytical evaluation of morphological, proteomic, and genetic features at the single-cell level, combining AI-driven imaging analysis with advanced genetic sequencing for maximum sensitivity and specificity in various clinical settings. The company aims to make liquid biopsy widely available in clinical practice.
Tethis S.p.A
Tethis S.p.A. is a company focused on revolutionizing cancer management through liquid biopsy. They offer a unique, automated, and standardized approach to processing blood samples, preserving sample integrity for early cancer detection and treatment guidance. Their proprietary See.d® platform and Smart Bio Surface (SBS) slides enable immediate, gentle, and efficient cell adhesion for a total capture approach to liquid biopsy. This allows for comprehensive analytical evaluation of morphological, proteomic, and genetic features at the single-cell level, combining AI-driven imaging analysis with advanced genetic sequencing for maximum sensitivity and specificity in various clinical settings. The company aims to make liquid biopsy widely available in clinical practice.